Literature DB >> 32105635

Electronic Cigarette Aerosol Modulates the Oral Microbiome and Increases Risk of Infection.

Smruti Pushalkar1, Bidisha Paul1, Qianhao Li1, Jian Yang1, Rebeca Vasconcelos1, Shreya Makwana1, Juan Muñoz González1, Shivm Shah1, Chengzhi Xie1, Malvin N Janal2, Erica Queiroz1, Maria Bederoff1, Joshua Leinwand3, Julia Solarewicz1, Fangxi Xu1, Eman Aboseria1, Yuqi Guo1, Deanna Aguallo1, Claudia Gomez1, Angela Kamer1, Donna Shelley4, Yindalon Aphinyanaphongs5, Cheryl Barber1, Terry Gordon6, Patricia Corby7, Xin Li8, Deepak Saxena9.   

Abstract

The trend of e-cigarette use among teens is ever increasing. Here we show the dysbiotic oral microbial ecology in e-cigarette users influencing the local host immune environment compared with non-smoker controls and cigarette smokers. Using 16S rRNA high-throughput sequencing, we evaluated 119 human participants, 40 in each of the three cohorts, and found significantly altered beta-diversity in e-cigarette users (p = 0.006) when compared with never smokers or tobacco cigarette smokers. The abundance of Porphyromonas and Veillonella (p = 0.008) was higher among vapers. Interleukin (IL)-6 and IL-1β were highly elevated in e-cigarette users when compared with non-users. Epithelial cell-exposed e-cigarette aerosols were more susceptible for infection. In vitro infection model of premalignant Leuk-1 and malignant cell lines exposed to e-cigarette aerosol and challenged by Porphyromonas gingivalis and Fusobacterium nucleatum resulted in elevated inflammatory response. Our findings for the first time demonstrate that e-cigarette users are more prone to infection.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  In Vitro Toxicology; Microbiome; Oral Microbiology

Year:  2020        PMID: 32105635      PMCID: PMC7113564          DOI: 10.1016/j.isci.2020.100884

Source DB:  PubMed          Journal:  iScience        ISSN: 2589-0042


Introduction

Electronic cigarettes (e-cigarettes), non-combustible battery-operated devices, are considered to be a safe and healthier alternative to conventional combustible cigarette smoke (Beaglehole et al., 2019). However, according to the Centers for Disease Control and Prevention (CDC), the US Food and Drug Administration (FDA), and the National Cancer Institute analysis of the 2011–2018 National Youth Tobacco Surveys data, to estimate tobacco product use in US middle and high school students, it was reported that in 2018, the current use of any tobacco product was 27.1% in high school students (4.04 million) and 7.2% in middle school students (840,000); e-cigarettes were the most commonly used product among high school (20.8%; 3.05 million) and middle school (4.9%; 570,000) students (Gentzke et al., 2019). Interestingly, e-cigarette vaping swelled by 77.8% (from 11.7% to 20.8%) among high school students and 48.5% (from 3.3% to 4.9%) among middle school students in the year 2017–2018 (Gentzke et al., 2019). These figures are of great concern due to the mounting popularity of e-cigarette usage among teenagers having never smoked any combustible products. Unlike traditional cigarettes with tobacco filling, which approximates 24 mg of nicotine per pack (1.2 mg/cigarette), e-cigarette liquid contains nicotine (Cameron et al., 2013) that varies between 6 and 48 mg/mL (Cameron et al., 2013) and is not meant to be smoked completely in one sitting (Etter and Bullen, 2011). Each nicotine cartridge in an e-cigarette can provide on an average 200 puffs equivalent to one to three packs of cigarettes. The nicotine absorption in the body from e-cigarette use depends on the nicotine concentration in the e-liquid, its aerosol mass quantity and deposition, the chemical form of the nicotine, as well as the vaping volume, frequency, and timing (Etter, 2014). As per a 2014 report, the US FDA detected in one of the cartridges the presence of diethylene glycol, a toxic liquid used in explosives and as an antifreeze agent, in addition to, cancer-causing agents, such as tobacco-specific nitrosamines, aldehydes, metals, volatile organic compounds, phenolic compounds, polycyclic aromatic hydrocarbons, flavors, solvent carriers, tobacco alkaloids, and drugs (amino tadalafil and rimonabant) (Cheng, 2014). Moreover, recent studies showed that nicotine delivery and emission of some toxicant levels from the latest generation of e-cigarettes were comparable to those from tobacco smoke (Eltorai et al., 2019). The oral cavity is a gateway and a permanent or makeshift harbor for numerous microbial species to colonize the respiratory and gastrointestinal (GI) tracts (Saxena et al., 2012). The multifactorial pathogenicity of chronic periodontal disease involves a complex interaction of microbial pathogens, host immune response, and genetic and environmental factors, stimulating the host tissue destruction and bone loss (Harvey, 2017). Certain oral bacteria, Porphyromonas gingivalis and Fusobacterium nucleatum, are major perpetrators in periodontal destruction, highly associated with disease progression (Tâlvan et al., 2017). The release of host immune mediators as a primary response to these opportunistic pathogens (pathobionts) and its metabolites favors the disease state. The dysbiosis in microbial communities due to impaired homeostasis as a result of environmental and host metabolic factors can contribute to oral diseases, including dental caries, periodontitis, halitosis, or other medical ailments, such as diabetes, cardiovascular diseases, and cancers (He et al., 2015). Elaborate studies have shown the toxicity of conventional tobacco product consumption to periodontal health (Kumar et al., 2011), albeit with very limited understanding on e-cigarette's effect (Stewart et al., 2018). The e-cigarette aerosol interaction with the host ensues largely in the oral cavity and lungs, where the exposure to nicotine and toxic metabolites of the e-liquid components is the highest and can escalate the host susceptibility to infections (Cheng, 2014). Recent reports associate e-cigarette vaping with vascular endothelial dysfunction causing blood-brain barrier damage with higher risk of cerebrovascular diseases (Sivandzade and Cucullo, 2019). Hence, it is imperative to elucidate the detrimental effect of e-liquids on the host inflammatory responses, which is highly challenging and conflicting. The lucrative e-cigarette vaping delivery systems, available in a variety of flavors and concentrations, can pose a substantial threat to human health (Gentzke et al., 2019). Wu et al. (2014) have shown that e-liquids induce inflammatory responses and alter innate immune defenses in primary airway epithelial cells. The findings of Sussan et al. (2015) indicated that exposure of C57BL/6 mice to e-cigarette aerosols for 2 weeks can cause impairment of pulmonary bacterial and viral clearance. Accordingly, in vitro studies can be extrapolated to recognize responses by electronic nicotine delivery system users, however, without the clinical evidence of smoking history (Kaur et al., 2018). So, to understand the comprehensive health effects of vaping it is essential to conduct clinical research in conjunction with in vitro e-cigarette aerosol-exposed model. This will further help us to associate and understand the impact of vaping on human health by gauging the positive and negative controls. Here, we report the in vivo effects of e-cigarette aerosol and its influence on human salivary microbiome and immune health. Furthermore, we evaluate in vitro the influence of e-cigarette aerosols on infection efficiency of oral pathogens in pre-cancerous and cancer cell lines using a novel e-cigarette aerosol-generating machine and pro-inflammatory immune mediators.

Results

To assess the in vivo influence of smoking on microbial profiles of recruited participants, we stratified 119 subjects according to their smoking status into each of the three cohorts (never smokers [NS, n = 39], e-cigarette users [ES, n = 40], and regular cigarette smokers [CS, n = 40]). The demographic details of all the subjects and smoking history were collected at the baseline for the ES and CS groups (Table S1). The ES and CS cohorts had a nearly equal percentage of male population (∼77%–80%). On the other hand, females were higher at 43.6% in the NS cohort. Participants exclusively using e-cigarettes vaped on an average 0.5 e-cigarettes per day, whereas participants exclusively using combustible cigarettes smoked an average of 11 cigarettes per day. There was no significant change in the salivary flow rate across the participants in different cohorts. The severity index of periodontal disease or infection was significantly higher among CS (72.5%), followed by ES (42.5%), and non-smokers (28.2%), as also reflected by the calculated mean pocket depth among cohorts. This was confirmed by the values of bleeding on probing (BoP), one of the markers for inflammation, elevated in CS and receding in e-cigarette vapers and non-smokers, although with no statistical significance. To determine the participants' smoking status, exhaled breath carbon monoxide (CO) levels (ppm) and salivary cotinine levels (ng/mL) were evaluated. Figures 1A and 1B, respectively, illustrate the cohort-based distribution of the smoking biomarkers for CO levels in exhaled breath and salivary cotinine levels in the participants. The CO and the salivary cotinine levels were the lowest in non-smokers and the highest among traditional cigarette users (Table S1).
Figure 1

Breath Carbon Monoxide and Salivary Cotinine Levels in NS, ES and CS Cohorts as a Measure of Tobacco Smoke Exposure Resulting in Skewed Bacterial Communities

(A) Levels of breath carbon monoxide (ppm) across the subjects (in percentage) in the non-smokers (NS), e-cigarette users (ES), and cigarette smokers (CS); non-smoker (NONS): 0–6 ppm, borderline (BdL): 7–9 ppm, low addicted smoker (LAS): 10–15 ppm, moderate addicted smoker (MAS): 16–25 ppm, heavily addicted smoker (HAS): 26–35 ppm, and very heavily addicted smoker (VHAS): 36+ ppm.

(B) Distribution of salivary cotinine levels in the participants of the three cohorts.

(C–F) Weighted UniFrac 3D PCoA plots illustrating beta diversity of salivary bacterial taxa across all the samples. (C) Three cohorts, NS, ES, and CS (p < 0.001); (D) between NS and ES cohorts (p = 0.005); (E) between ES and CS cohorts (p = 0.006); and (F) between NS and CS cohorts (p < 0.001). Green, never smokers (NS); blue, e-cigarette vapers (ES); and red, cigarette smokers (CS). Ellipses indicate 95% confidence interval.

Breath Carbon Monoxide and Salivary Cotinine Levels in NS, ES and CS Cohorts as a Measure of Tobacco Smoke Exposure Resulting in Skewed Bacterial Communities (A) Levels of breath carbon monoxide (ppm) across the subjects (in percentage) in the non-smokers (NS), e-cigarette users (ES), and cigarette smokers (CS); non-smoker (NONS): 0–6 ppm, borderline (BdL): 7–9 ppm, low addicted smoker (LAS): 10–15 ppm, moderate addicted smoker (MAS): 16–25 ppm, heavily addicted smoker (HAS): 26–35 ppm, and very heavily addicted smoker (VHAS): 36+ ppm. (B) Distribution of salivary cotinine levels in the participants of the three cohorts. (C–F) Weighted UniFrac 3D PCoA plots illustrating beta diversity of salivary bacterial taxa across all the samples. (C) Three cohorts, NS, ES, and CS (p < 0.001); (D) between NS and ES cohorts (p = 0.005); (E) between ES and CS cohorts (p = 0.006); and (F) between NS and CS cohorts (p < 0.001). Green, never smokers (NS); blue, e-cigarette vapers (ES); and red, cigarette smokers (CS). Ellipses indicate 95% confidence interval.

Altered Bacterial Richness and Diversity in e-Cigarette Users

The salivary microbiome in 119 participants in the NS, ES, and CS groups was analyzed using 8,254,494 high-quality filtered 16S sequences (mean 68,787 ± 19,758 SD). The salivary microbiome was composed of 11 phyla, 22 classes, 33 orders, 55 families, 99 genera, 162 species, and 911 operational taxonomic units (OTUs). Principal coordinate analyses (PCoA) were performed to determine the overall microbiome composition in the three cohorts. Based on the weighted UniFrac distance matrix generated from all the samples in each cohort, we observed significant differences (p < 0.05, PERMANOVA) in the microbial composition between the three cohorts (Figure 1C) and additionally, between each cohort in an independent combinatorial comparison (Figures 1D–1F). These results suggest that the microbiome structure in each of the three cohorts was distinct. Interestingly, a few of the individual ES cohort samples showed an overlap with some samples in the NS (Figure 1D) and CS (Figure 1E) cohorts, although they were significantly distinct microbiomes. These findings were reiterated by double PCoA that establishes differences in taxonomic signatures (Figure 2C) in context to breath CO levels (Figure 2A) and salivary cotinine levels (Figure 2B) of the participants.
Figure 2

Abundance of Microbiota with Respect to Carbon Monoxide Concentration, Cotinine Levels and Smoking Status

(A–E) Double PCoA plots showing taxa correlating to the smoking status, in terms of (A) breath CO levels (in percentage), (B) cotinine levels, and (C) phyla taxonomy in the non-smokers (NS), e-cigarette users (ES), and cigarette smokers (CS); non-smoker (NonS): 0–6 ppm, borderline (BdL): 7–9 ppm, low addicted smoker (LaS): 10–15 ppm, moderate addicted smoker (MaS): 16–25 ppm, heavily addicted smoker (HaS): 26–35 ppm, and very heavily addicted smoker (VHaS): 36+ ppm, data not available (na). (D) Alpha diversity as measured by observed species, Shannon diversity index, and phylogenetic diversity (PD) of the salivary microbiome in NS (green), ES (blue), and CS (red) cohorts. The line inside the box represents the median, whereas the whiskers represent the lowest and highest values within the interquartile range. Outliers' individual samples are shown as dots. Analysis was done using Mann-Whitney test. (E) Phylum-level relative abundances of the salivary microbiota based on taxonomic inference of 16S rRNA sequences. Actinobacteria, Firmicutes, Fusobacteria, Proteobacteria, and Spirochaetes were significantly altered. (D and E) Data are represented as mean ± SEM. (*p < 0.05, **p < 0.01, ***p < 0.001).

Abundance of Microbiota with Respect to Carbon Monoxide Concentration, Cotinine Levels and Smoking Status (A–E) Double PCoA plots showing taxa correlating to the smoking status, in terms of (A) breath CO levels (in percentage), (B) cotinine levels, and (C) phyla taxonomy in the non-smokers (NS), e-cigarette users (ES), and cigarette smokers (CS); non-smoker (NonS): 0–6 ppm, borderline (BdL): 7–9 ppm, low addicted smoker (LaS): 10–15 ppm, moderate addicted smoker (MaS): 16–25 ppm, heavily addicted smoker (HaS): 26–35 ppm, and very heavily addicted smoker (VHaS): 36+ ppm, data not available (na). (D) Alpha diversity as measured by observed species, Shannon diversity index, and phylogenetic diversity (PD) of the salivary microbiome in NS (green), ES (blue), and CS (red) cohorts. The line inside the box represents the median, whereas the whiskers represent the lowest and highest values within the interquartile range. Outliers' individual samples are shown as dots. Analysis was done using Mann-Whitney test. (E) Phylum-level relative abundances of the salivary microbiota based on taxonomic inference of 16S rRNA sequences. Actinobacteria, Firmicutes, Fusobacteria, Proteobacteria, and Spirochaetes were significantly altered. (D and E) Data are represented as mean ± SEM. (*p < 0.05, **p < 0.01, ***p < 0.001). The alpha diversity indices, such as observed OTUs, Shannon index, and phylogenetic diversity were computed to determine the microbial diversity within the three groups (Figure 2D). We observed a significantly higher number of observed OTUs (p = 0.023) and phylogenetic diversity (p = 0.002) in non-combustible vapers when compared with NS. No significant changes were detected in the diversity indices of the CS cohort when compared with NS and ES users. All the analysis was done using Mann-Whitney test with a confidence level of 99% (p ≤ 0.01) in each index.

Abundance of Oral Microbial Taxa in e-Cigarette Vapers

The relative abundance of salivary microbiome differed between non-combustible vapers and combustible smokers when compared with healthy non-smoking controls. The five most abundant taxa observed were Firmicutes, Proteobacteria, Bacteroidetes, Actinobacteria, and Fusobacteria, which accounted for 97.5% of the total sequences (Figure 2E). Intriguingly, Proteobacteria predominated the ES cohort with significantly lower levels in the CS cohort (p < 0.0001). The CS and ES showed significantly elevated salivary Actinobacteria compared with NS (p < 0.0001 and p < 0.01, respectively). However, Firmicutes were highly enriched in the saliva of the CS cohort compared with those of the ES (p < 0.01) and NS (p < 0.0001) cohorts. On the contrary, Fusobacteria exhibited significant depletion in the CS cohort when compared with the ES (p < 0.024) and NS (p < 0.001) cohorts. Another predominant taxon, Spirochaetes, proliferated in the CS cohort (p < 0.005). The salivary microbiome in the three cohorts was significantly dominated by eight taxa; Streptococcus, Veillonella, Prevotella, Neisseria, Haemophilus, Porphyromonas, Rothia, and Fusobacterium, which constituted 79.15% of all the sequences (Figures 3A and 3B). Other differentially abundant taxa identified were Leptotrichia, Gemella, and Capnocytophaga (Figures 3A and 3B). A hierarchical cluster analysis showed stratification of taxa into four clusters (Figure 3C). Interestingly, the ES salivary microbiota that harbored Cluster Ib and Cluster IIb showed resemblance to those taxa distinct in NS and CS cohorts, respectively (Figure 3C). A similar pattern was also observed in the weighted PCoA plot (Figure 1C). Further analyses revealed these similarities to be closely associated with the nicotine intake (smoking status) by the ES participants. Cumulatively, the taxa observed to be proliferated were Actinomyces in the ES cohort, TM7 in the ES and NS cohorts, and Granulicatella in the NS cohort. Moreover, Neisseria and Fusobacterium were significantly associated with the ES and NS cohorts compared with the CS cohort, p < 0.0001, whereas the opportunistic pathogens, Streptococcus (p < 0.01), Prevotella (p = 0.01), and Rothia (p = 0.002) were differentially enriched in the CS cohort. Veillonella levels increased significantly by ∼4% in ES (p = 0.008) and ∼4.5% (p = 0.001) in CS cohorts than NS cohorts. These findings suggest microbial dysbiosis in non-combustible vapers and combustible smokers.
Figure 3

Dysbiotic Salivary Bacterial Genera in NS, ES, and CS Cohorts

(A) Cohort-based microbial abundances observed in NS, ES, and CS cohorts.

(B) Heat tree illustrates the relationship of OTUs up to genus level. Colored branch of the tree denotes significance based on the color of individual cohorts.

(C) Top 20 taxa in the saliva of the subject population across NS, ES, and CS cohorts; rectangular boxes represents two clusters where several taxa in the samples of ES cohort overlap with the samples of NS and CS cohorts.

Dysbiotic Salivary Bacterial Genera in NS, ES, and CS Cohorts (A) Cohort-based microbial abundances observed in NS, ES, and CS cohorts. (B) Heat tree illustrates the relationship of OTUs up to genus level. Colored branch of the tree denotes significance based on the color of individual cohorts. (C) Top 20 taxa in the saliva of the subject population across NS, ES, and CS cohorts; rectangular boxes represents two clusters where several taxa in the samples of ES cohort overlap with the samples of NS and CS cohorts. A heat tree illustrates the relationships of species-specific OTUs in the NS, e-cigarette vapers, and CS (Figure S1). Streptococcus oralis subsp. tigurinus clade 071, Porphyromonas pasteri, Fusobacterium periodonticum, and Oribacterium parvum were depleted significantly in the ES and CS cohorts (Figures S2A and S2B). On the contrary, abundance of Veillonella rogosae, Granulicatella adiacens, and Prevotella sp. HMT 317 was higher in the NS cohort. Veillonella dispar, Porphyromonas endodontalis, Fusobacterium nucleatum subsp. vincentii, Prevotella oris, and Parvimonas micra predominated substantially in the ES and CS cohorts (Figures S2A and S2B). Veillonella atypica, Megasphaera micronuciformis, Streptococcus parasanguinis clade 411, Prevotella sp. HMT 311, and Actinomyces lingnae, although higher in the ES cohort, significantly expanded in the CS cohort (Figure S2C). P. gingivalis, Alloprevotella tannerae, Dialister invisus, Corynebacterium durum, and Leptotrichia wadei levels were proliferated in the ES cohort, whereas Streptococcus salivarius was higher in the CS cohort.

In vivo Interactions among Oral Taxa and Salivary Cytokines

To explore the salivary inflammatory markers in all participants, 39 in NS cohort and 40 in each of ES and CS cohorts, we analyzed 10 different cytokines using a human multiplex immune assay pro-inflammatory panel. Salivary interleukin (IL)-6 and IL-1β were elevated, although not significant in ES when compared with NS and CS (Figure 4A). Significant reduction in levels of interferon (IFN)-γ and IL-4 were observed in traditional CS compared with NS. Tumor necrosis factor (TNF)-α concentrations were altered significantly in non-smokers (p < 0.05) and considerably in ES (p < 0.1) compared with regular CS. However, other salivary cytokines showed no significant difference among cohorts. We further evaluated the association between inflammatory cytokines and salivary bacteria. Spearman correlation analysis indicated Porphyromonas, Haemophilus, Catonella, and Niesseria to be positively correlated with cytokines IL-2, IL-13, IL-8, and IL-1β (Figure 4B). In addition, Lachnoanaerobaculum and Stomatobaculum displayed positive correlation toward inflammatory immune indicators such as IL-2, IL-4, IL-8, IL-13, IL-10, IL-12p70, and IFN-γ (Figure 4B). Positive correlations were observed among Parvimonas, Peptostreptococcus, and Mogibacterium with IL-8 and IL-1β, and significant correlations were observed in Fusobacterium, Johnsonella, and Catonella with IL-1β. On the contrary, among a few taxa inverse correlation was observed, i.e., Desulfovibrio, Dialister, Helicobacter, Peptostreptococcus, Olsenella, and Treponema with TNF-α; Bacteroides with IL-6; Tannerella with TNF-α, IL-4, and IFN-γ; and Corynebacterium and Olsenella with IL-8.
Figure 4

Salivary Inflammatory Cytokine Expression and Its Correlation with Abundant Taxa

(A and B) (A) Levels of 10 different pro-inflammatory salivary cytokines and chemokines in three cohorts, NS, ES, and CS. Data are represented as mean ± SEM. (#p < 0.1, *p < 0.05). (B) Correlation matrices indicate association of cytokines with the bacterial taxa. Values are represented by colors from blue (negative correlation) to red (positive correlation). Clustering is based on the Spearman rank correlation similarity between cytokines and microbial genera. (*p < 0.05, **p < 0.01)

Salivary Inflammatory Cytokine Expression and Its Correlation with Abundant Taxa (A and B) (A) Levels of 10 different pro-inflammatory salivary cytokines and chemokines in three cohorts, NS, ES, and CS. Data are represented as mean ± SEM. (#p < 0.1, *p < 0.05). (B) Correlation matrices indicate association of cytokines with the bacterial taxa. Values are represented by colors from blue (negative correlation) to red (positive correlation). Clustering is based on the Spearman rank correlation similarity between cytokines and microbial genera. (*p < 0.05, **p < 0.01) To confirm and expand the relevance of the aforementioned in vivo findings, we next performed in vitro studies using the premalignant (Leuk-1) and malignant (Fadu) cell lines exposed to e-cigarette aerosols. We evaluated the altered pro-inflammatory cytokine response at mRNA and protein levels when co-cultured with the periodontal pathogens, P. gingivalis and F. nucleatum, the taxa observed to be expanded in vivo in the saliva of ES, and with E. coli GFP, one of the most established models of infection.

In Vitro mRNA Levels of Pro-inflammatory Cytokines Are Altered in the Presence of e-Cigarette Aerosols

Fadu and Leuk-1 cells were exposed to e-cigarette aerosol or air for 40 min followed by infection with P. gingivalis and F. nucleatum for 2 h (Figures 5A and 5B). Initially, we exposed malignant Fadu cells to either air or e-cigarette aerosols followed by infection with each of these bacteria. We quantified the mRNA levels of the cytokines, IL-1β, TNF-α, IFN-γ, IL-6, and IL-8 by qPCR. A significant rise in all the five cytokine mRNA levels was detected in e-cigarette aerosol-exposed Fadu cells co-infected with P. gingivalis when compared with those exposed to only air co-infected with same bacteria. Intriguingly, TNF-α showed almost a 30-fold increase in expression when compared with the cells exposed only to air. Similarly, higher mRNA levels of cytokines were observed when e-cigarette aerosol-exposed Fadu cells were co-infected with F. nucleatum. The expansion in mRNA expression of IFN-γ was highly significant, followed by IL-6, IL-8, and IL-1β, and moderate for TNF-α upon e-cigarette aerosol exposure for Fadu cells. We further assessed the mRNA levels of TNF-α and IL-8 in the Leuk-1 cell line infected with P. gingivalis and F. nucleatum and observed results similar to that with Fadu cell line (Figures S3A and S3B). Significantly high mRNA expression of IL-8 was observed in e-cigarette aerosol-exposed cells with both bacteria.
Figure 5

mRNA Expression Levels of Various Cytokines, TNF-α, IL-8, IFN-γ, IL-1β, and IL-6 in Fadu Cells in the Presence of Bacteria and e-Cigarette Aerosols as Determined by qPCR.

(A–C) Significant increase in expression of all cytokine mRNAs was observed with (A) P. gingivalis (B) F. nucleatum, and (C) E. coli GFP. Cells exposed to only air or e-cigarette aerosol were used as controls. Data are represented as mean ± SEM. (*p < 0.05, **p < 0.01, ***p < 0.001).

mRNA Expression Levels of Various Cytokines, TNF-α, IL-8, IFN-γ, IL-1β, and IL-6 in Fadu Cells in the Presence of Bacteria and e-Cigarette Aerosols as Determined by qPCR. (A–C) Significant increase in expression of all cytokine mRNAs was observed with (A) P. gingivalis (B) F. nucleatum, and (C) E. coli GFP. Cells exposed to only air or e-cigarette aerosol were used as controls. Data are represented as mean ± SEM. (*p < 0.05, **p < 0.01, ***p < 0.001). Furthermore, we examined whether a similar influence on cytokines is observed when Fadu cells were infected with the classical microbe, E. coli GFP (Figure 5C). Upon co-infection with this bacteria, the e-cigarette aerosol-exposed Fadu cells exhibited significantly higher mRNA levels of IL-1β and IFN-γ in contrast to air-exposed bacterial co-infected cells. In parallel, the IL-8 mRNA expression was up-regulated significantly in Fadu cells exposed to e-cigarette aerosol and E. coli GFP when compared with cells exposed singly to either air or e-cigarette. TNF-α, IL-8, IFN-γ, IL-1β, and IL-6 mRNA expression was also measured in Leuk-1 cells in the presence of E. coli GFP, and e-cigarette aerosols caused a significant rise in cytokine levels (Figure S3C). The findings suggested augmented cytokine mRNA expression in Fadu as well as Leuk-1 cells upon e-cigarette aerosol exposure, and even more so when co-infected with bacteria, indicating increased susceptibility to infection in cells when exposed to e-cigarette aerosols.

e-Cigarette Aerosol Exposure Increased the Protein Levels of Pro-inflammatory Cytokines In Vitro

Fadu cells infected with P. gingivalis, showed significant up-regulation of IL-8 protein in the presence of e-cigarette aerosol when compared with air exposure. However, TNF-α protein levels did not significantly change in the cells infected with P. gingivalis and F. nucleatum (Figures 6A and 6B). On the contrary, under similar conditions with F. nucleatum, IL-8 and TNF-α protein levels were differentially up-regulated when compared with air only. However, these protein cytokine levels were not in the detectable range with E. coli GFP (data not shown).
Figure 6

Protein Cytokine Concentration of TNF-α and IL-8 in Bacteria-Treated Fadu Cell-Free Medium upon e-Cigarette Aerosol Exposure as Quantified by ELISA Assay

Cytokine protein levels were up-regulated with e-cigarette aerosol exposure: (A) IL-8 only with P. gingivalis and (B) TNF-α only with F. nucleatum. Data are represented as mean ± SEM. (*p < 0.05, ***p < 0.001, ****p < 0.0001).

Protein Cytokine Concentration of TNF-α and IL-8 in Bacteria-Treated Fadu Cell-Free Medium upon e-Cigarette Aerosol Exposure as Quantified by ELISA Assay Cytokine protein levels were up-regulated with e-cigarette aerosol exposure: (A) IL-8 only with P. gingivalis and (B) TNF-α only with F. nucleatum. Data are represented as mean ± SEM. (*p < 0.05, ***p < 0.001, ****p < 0.0001). In addition, when another cell line Leuk-1 was tested, up-regulated IL-8 level protein upon e-cigarette aerosol exposure was observed. Conversely, co-infection of Leuk-1 with P. gingivalis did not show a similar effect, where TNF-α levels were not altered (Figure S4A). However, infection with F. nucleatum showed higher protein concentration of both TNF-α and IL-8 in e-cigarette aerosol-exposed cells (Figure S4B). Leuk-1 cells co-infected with E.coli GFP in the presence of e-cigarette aerosols significantly up-regulated IL-8 protein. However, the TNF-α protein levels could not be detected with ELISA due to the very low levels of expression (Figure S4C). Our in vitro results clearly indicated that e-cigarette aerosols altered the cytokine concentration at mRNA and protein levels in the presence of periodontal pathogens, as was also confirmed with E. coli GFP.

e-Cigarette Aerosols Accelerate Oral Bacterial Infection

To affirm that the e-cigarette aerosol influenced the rate of microbial infection in vitro, FaDu cells were co-cultured with either P. gingivalis or F. nucleatum pre-labeled with fluorescein isothiocyanate and then exposed to air or e-cigarette aerosol, and the infected FaDu cell population was evaluated by flow cytometry. It was observed that P. gingivalis and F. nucleatum infection in Fadu cells with e-cigarette aerosol contact increased significantly (p < 0.05) by about 65% and 16%, respectively, compared with air only (Figures S5A and S5B). Furthermore, FaDu cells were also infected with E.coli GFP in a 1:50 ratio after treating with either air or e-cigarette aerosol. Infection efficiency determined by GFP expression with flow cytometry showed a significant elevation (p < 0.048) of almost 21% in FaDu cells exposed to e-cigarette aerosol than in those exposed only to air (Figure S5C).

Discussion

Although e-cigarettes are conjectured to be an effective alternative to conventional cigarette smoking, statistical data insinuate an exponential rise in e-cigarette usage among college students, and its co-use with alcohol can contribute to negative consequences in the current younger generation (Littlefield et al., 2015). Also, there is limited information on the effects of nicotine content in the e-cigarette on oral microbiota and periodontal infection. This study assessed the influence of different host smoking environments on periodontal health analogous to host immune response and salivary microbial profiles. We observed that distinct microbial communities harbor the oral cavity of ES, albeit exhibiting some community overlap with either NS or conventional CS participants. Interestingly, the e-cigarette vapers that had overlapping taxa clustering with either the NS or CS cohorts presented moderate to severe periodontitis. In addition, the e-cigarette participants who shared higher abundance of certain microbial communities (Figure 3C) with the non-smoker cohort and with conventional smokers had BoP of 56.09% and 65.49%, respectively, which reflects high inflammatory fingerprint in CS participants. An earlier study has shown an association between periodontal status and the microbiota, with increased counts of several bacteria including periodonto-pathogens, P. gingivalis, Treponema denticola, Tannerella forsythia, and Niesseria mucosa with increased inflammatory biomarkers in the saliva of periodontal disease-positive non-smokers (n = 366) (Lira-Junior et al., 2018). This connotes dependencies for dysbiotic microbial communes on periodontal health status, as signified by pocket depth and inflammatory responses, a measure of bleeding on probing and observed cytokine levels, in addition to salivary cotinine levels. The exposure to nicotine or other components from e-cigarette vaping expanded the abundance of periodontal pathogens. Periodontal microbes are a potential source of oral bacterial consortia that is altered by smoking, as reported earlier in the intervention studies for treatments of periodontal disease and tobacco dependence (Delima et al., 2010). It is well established that smoking-associated periodontitis is not just a deliberation of poor oral hygiene but extends to provide an appropriate niche for colonization of bacteria such as P. gingivalis, Prevotella intermedia, and Actinobacillus actinomycetemcomitans, facilitating development of periodontal lesions (Eggert et al., 2001). It has been reported that exposure to nicotine modulated the immunological functions via P. gingivalis, promoting biofilm formation by interacting with commensal oral bacteria Streptococcus gordonii (Hanioka et al., 2019). Moreover, the salivary microbiome exemplifies bacteria from different surfaces in the oral cavity (Gao et al., 2018). Socransky and Haffajee (2005) observed a higher prevalence of eight species, including P. gingivalis, in current smokers. Socransky et al. (1998) showed that several bacterial complexes are involved in the etiology of periodontitis. The red complex (P. gingivalis, T. forsythia, and T. denticola) and orange complex (F. nucleatum subspecies, F. periodonticum, Peptostreptococcus micros, Prevotella intermedia, Prevotella nigrescens, and Campylobacter rectus) perio-pathogens indicate high and moderate risks, respectively, of periodontitis (Socransky et al., 1998) as detected in our study. Moreover, we observed a significant proliferation of specific salivary taxa, to note, Veillonella in ES and regular CS when compared with NS. Nonetheless, Porphyromonas expanded significantly in ES, whereas Prevotella did in conventional CS. The taxon Granulicatella was predominant in all the three cohorts. The predominance of these periodontal pathogens in the oral cavity of ES and combustible cigarette users is a reflection of severely compromised periodontal health (p = 0.001) as depicted in Table S1. It has been shown that nicotine and its metabolite cotinine, as well as treatment with a cigarette smoke extract, can alter the function of key periodontal pathogens such as P. gingivalis and promote biofilm formation, colonization, and infection (Hanioka et al., 2019). Granulicatella is a known commensal of the human oral microbiome, however, which has been implicated in endodontic infection (Siqueira and Rôças, 2006) and is linked to increased risk of systemic diseases, such as pancreatic cancer related to oral inflammation (Farrell et al., 2012). Cigarette smoking is known to escalate the infection risk of pathogenic or opportunistic bacteria by bringing about physiological and structural changes, increases in bacterial virulence, and immune dysfunction (Bagaitkar et al., 2008). A sophisticated cytokine network regulates the cross talk between periodontal pathogens and immune mediators. The extent of the host inflammatory response to a microbial challenge defines the severity of periodontal disease (Harvey, 2017). IL-1β concentrations were found to be significantly higher along with the progression of periodontal disease (Tâlvan et al., 2017). Prevotella was found to be positively associated with the cytokine IL-1β, which suggests a high pro-inflammatory state (Acharya et al., 2017). Previous studies have indicated Peptostreptococcus (Riggio et al., 2001) as well as Mogibacterium and Catonella to be associated with periodontal and endodontic infections (Siqueira and Rôças, 2006). In the present study, Veillonella was found to be a highly abundant taxon, specifically with species V. atypica and V. rogosae being highly elevated in ES and CS cohorts. Veillonella are largely commensals, abundantly existing in saliva and on dorsal and lateral surfaces of the tongue (Mager et al., 2003), and have conflicting (i.e., positive, negative, or no) associations with cigarette smoking in patients with periodontitis (Kato et al., 2016). Previous reports suggest that V. atypica specifically converts ingested nitrate, largely present in the saliva of tobacco users, to nitrite, which can further be converted to potentially toxic carcinogenic nitrosamines and pro-inflammatory nitric oxide (Stepanov et al., 2008). These compounds can have pathophysiological consequences on oral and systemic health. Furthermore, tobacco exposure suppresses overall immune responsiveness to bacteria and bacterial by-products such as lipopolysaccharides (LPS) (Bagaitkar et al., 2008). Similar to our in vivo results showing increased salivary IL-6 production in ES, our in vitro study also asserted up-regulation of IL-6 after exposure to e-cigarette aerosols in Fadu and Leuk-1 cells. Moreover, in the presence of P. gingivalis alone (without e-cigarette aerosols), increased IL-6 expression in Fadu and Leuk-1 cells was detected. P. gingivalis is known to affect leukocyte distribution near microbial colonization sites disrupting the innate host surveillance (Hajishengallis et al., 2012, How et al., 2016). The observed enhanced IL-6 expression after infection with bacteria, including P. gingivalis, F. nucleatum, and E. coli GFP, suggests that e-cigarette aerosols enhanced susceptibility to periodontal disease. Both P. gingivalis and F. nucleatum play pivotal roles in periodontal disease and act on macrophages, neutrophils, and monocytes to induce TNF-α, IL-6, and IL-8 production (Petković et al., 2010). TNF-α secreted by immune cells can block bone formation and inhibit collagen synthesis (Fleetwood et al., 2017). IL-1β synergistically acts with TNF-α in the bone resorption process, and relatively high IL-1β concentrations are reported in the gingival crevicular fluid of patients with severe periodontal disease (Boström et al., 2000). Also, F. nucleatum, ubiquitous in oral cavity, is associated with chronic aggressive periodontitis, gingivitis, and endodontic infections, with additional effects such as adverse pregnancy outcomes, GI disorders, and other infections (Han, 2015). Moreover, the LPS of F. nucleatum stimulates improved IL-1β and TNF-α production when compared with that of P. gingivalis (Lagha and Grenier, 2016). Our in vivo results indicated expanded IL-1β levels in the saliva of e-cigarette vapers that parallel the proliferated presence of certain periodontal pathogenic taxa, such as Porphyromonas and Fusobacteria, in this participating cohort. In addition, F. nucleatum, known to stimulate nuclear factor-κB-driven pro-inflammatory responses, induces colon cancer (Lagha and Grenier, 2016). Increasing evidence revealed IL-6, IL-1β, and TNF-α involvement in dental and periodontal disease including inflamed pulp and periapical lesions (Brekalo Pršo et al., 2007) and in stimulation of tissue degradation due to an increase in matrix metalloproteinases (Alevizos et al., 2001). Studies have indicated high IL-6 expression at both transcriptional and translational levels in gingival mononuclear cells of patients with periodontitis (Fujihashi et al., 1993). The periodontal microbes in tissues likewise stimulate chemokine IL-8 production, which induces a signal for accumulation and activation of neutrophils in local sites (Wilson et al., 1985). Importantly, IL-8 levels were expanded in Fadu cells after co-infection with E. coli GFP, P. gingivalis, or F. nucleatum and increased maximally in cells treated with bacteria and exposed to e-cigarette aerosols. Also, our results have shown an up-regulation of IFN-γ upon co-incubation with e-cigarette aerosols and E. coli GFP when compared with air only, e-cigarette only, and combination of air and bacteria. IFN-γ is a key player in immune responses in periodontal disease (Gemmell and Seymour, 2004) and in the activation of immunomodulation in mesenchymal stem cells. In vivo studies reported that mice, in the absence of IFN-γ, showed decreased bone loss after P. gingivalis infection in oral cavity (Meyle and Chapple, 2015). The limitations of this experimental design are that all in vitro experiments were done on cell culture models using oral pathogens, and it will be valuable to include primary cell or 3D oral tissue models and other canonical intracellular pathogen (e.g., Listeria) in our future experiments. The presented data suggest that vaping e-cigarettes causes oral environmental shifts and highly influences the colonization of complex heterogeneous microbial biofilms. More elaborate studies would help in identifying the detrimental effects of e-cigarette aerosols and its toxic components, albeit taking into consideration other confounding factors such as vaping behavior and the dual use of e-cigarettes and conventional cigarettes. With the advent of more advanced versions of e-cigarettes, users have greater control over the quantity of e-liquid usage, power, and airflow settings. In one study, higher plasma nicotine levels were detected in newer generation of e-cigarettes compared with a first-generation e-cigarette device (Farsalinos et al., 2014). Studies are also warranted to evaluate the long-term adverse effects of metal fumes and other contaminants associated with e-cigarette usage. As e-cigarettes have become commercially available only in the past 10–12 years, there is no study that assesses the long-term health hazards associated with their use. However, very recently, the CDC and FDA reported about 215 cases of mysterious lung illnesses, linked to e-cigarette usage and vaping among teens and young adults in 25 states, currently under investigation with state and federal health officials (https://www.cdc.gov/media/releases/2019/s0830-statement-e-cigarette.html, August 30, 2019). Consequently, detailed studies will help to elucidate the mechanism and pathways of host-microbe interactions when in contact with e-cigarette aerosols that could compromise oral, respiratory, and cardiovascular health and its implication in DNA damage with cancer as a potential consequence.

Limitations of the Study

The limitations of this experimental design are that all in vitro experiments were done on cell culture models using oral pathogens, and it will be valuable to include primary cell or 3D oral tissue models. We have used three bacteria to study the increase in infection after aerosol exposure; however, it will be helpful if other canonical intracellular pathogens (e.g., Listeria) are used in future experiments.

Methods

All methods can be found in the accompanying Transparent Methods supplemental file.
  46 in total

1.  Electronic Cigarette Use Among College Students: Links to Gender, Race/Ethnicity, Smoking, and Heavy Drinking.

Authors:  Andrew K Littlefield; Joshua C Gottlieb; Lee M Cohen; David R M Trotter
Journal:  J Am Coll Health       Date:  2015

2.  Salivary microbiome of an urban Indian cohort and patterns linked to subclinical inflammation.

Authors:  A Acharya; Y Chan; S Kheur; M Kheur; D Gopalakrishnan; R M Watt; N Mattheos
Journal:  Oral Dis       Date:  2017-05-24       Impact factor: 3.511

Review 3.  The oral microbiome diversity and its relation to human diseases.

Authors:  Jinzhi He; Yan Li; Yangpei Cao; Jin Xue; Xuedong Zhou
Journal:  Folia Microbiol (Praha)       Date:  2014-08-23       Impact factor: 2.099

Review 4.  Immunological and toxicological risk assessment of e-cigarettes.

Authors:  Gagandeep Kaur; Rakeysha Pinkston; Benathel Mclemore; Waneene C Dorsey; Sanjay Batra
Journal:  Eur Respir Rev       Date:  2018-02-28

5.  Proinflammatory cytokines (IL-1beta and TNF-alpha) and chemokines (IL-8 and MIP-1alpha) as markers of peri-implant tissue condition.

Authors:  A B Petković; S M Matić; N V Stamatović; D V Vojvodić; T M Todorović; Z R Lazić; R J Kozomara
Journal:  Int J Oral Maxillofac Surg       Date:  2010-03-05       Impact factor: 2.789

6.  Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices.

Authors:  Konstantinos E Farsalinos; Alketa Spyrou; Kalliroi Tsimopoulou; Christos Stefopoulos; Giorgio Romagna; Vassilis Voudris
Journal:  Sci Rep       Date:  2014-02-26       Impact factor: 4.379

7.  Metabolic Remodeling, Inflammasome Activation, and Pyroptosis in Macrophages Stimulated by Porphyromonas gingivalis and Its Outer Membrane Vesicles.

Authors:  Andrew J Fleetwood; Man K S Lee; William Singleton; Adrian Achuthan; Ming-Chin Lee; Neil M O'Brien-Simpson; Andrew D Cook; Andrew J Murphy; Stuart G Dashper; Eric C Reynolds; John A Hamilton
Journal:  Front Cell Infect Microbiol       Date:  2017-08-04       Impact factor: 5.293

Review 8.  Smoking and periodontal microorganisms.

Authors:  Takashi Hanioka; Manabu Morita; Tatsuo Yamamoto; Koji Inagaki; Pao-Li Wang; Hiroshi Ito; Toshiya Morozumi; Toru Takeshita; Nao Suzuki; Hideo Shigeishi; Masaru Sugiyama; Kouji Ohta; Toru Nagao; Nobuhiro Hanada; Miki Ojima; Hiroshi Ogawa
Journal:  Jpn Dent Sci Rev       Date:  2019-04-24

9.  Tumor necrosis factor-alpha and interleukin 6 in human periapical lesions.

Authors:  Ivana Brekalo Prso; Willy Kocjan; Hrvoje Simić; Gordana Brumini; Sonja Pezelj-Ribarić; Josipa Borcić; Silvio Ferreri; Ivana Miletić Karlović
Journal:  Mediators Inflamm       Date:  2006-12-27       Impact factor: 4.711

10.  Electronic cigarette liquid increases inflammation and virus infection in primary human airway epithelial cells.

Authors:  Qun Wu; Di Jiang; Maisha Minor; Hong Wei Chu
Journal:  PLoS One       Date:  2014-09-22       Impact factor: 3.240

View more
  27 in total

Review 1.  E-Cigarette Toxicology.

Authors:  Terry Gordon; Emma Karey; Meghan E Rebuli; Yael-Natalie H Escobar; Ilona Jaspers; Lung Chi Chen
Journal:  Annu Rev Pharmacol Toxicol       Date:  2021-09-23       Impact factor: 16.459

2.  Saliva and Lung Microbiome Associations with Electronic Cigarette Use and Smoking.

Authors:  Ewy A Mathe; Peter G Shields; Kevin L Ying; Theodore M Brasky; Jo L Freudenheim; Joseph P McElroy; Quentin A Nickerson; Min-Ae Song; Daniel Y Weng; Mark D Wewers; Noah B Whiteman
Journal:  Cancer Prev Res (Phila)       Date:  2022-07-05

3.  Effect of electronic cigarette and tobacco smoking on the human saliva microbial community.

Authors:  Xue Wang; Qili Mi; Ji Yang; Ying Guan; Wanli Zeng; Haiying Xiang; Xin Liu; Wenwu Yang; Guangyu Yang; Xuemei Li; Yinshan Cui; Qian Gao
Journal:  Braz J Microbiol       Date:  2022-03-01       Impact factor: 2.214

Review 4.  Policy, toxicology and physicochemical considerations on the inhalation of high concentrations of food flavour.

Authors:  Vlad Dinu; Azad Kilic; Qingqi Wang; Charfedinne Ayed; Abdulmannan Fadel; Stephen E Harding; Gleb E Yakubov; Ian D Fisk
Journal:  NPJ Sci Food       Date:  2020-10-07

Review 5.  Evaluation of periodontal indices among non-smokers, tobacco, and e-cigarette smokers: a systematic review and network meta-analysis.

Authors:  Paolo Pesce; Maria Menini; Giovanni Ugo; Francesco Bagnasco; Mario Dioguardi; Giuseppe Troiano
Journal:  Clin Oral Investig       Date:  2022-05-13       Impact factor: 3.606

Review 6.  Electronic Cigarettes and Head and Neck Cancer Risk-Current State of Art.

Authors:  Marta Szukalska; Krzysztof Szyfter; Ewa Florek; Juan P Rodrigo; Alessandra Rinaldo; Antti A Mäkitie; Primož Strojan; Robert P Takes; Carlos Suárez; Nabil F Saba; Boudewijn J M Braakhuis; Alfio Ferlito
Journal:  Cancers (Basel)       Date:  2020-11-05       Impact factor: 6.639

Review 7.  E-cigarettes use in the United States: reasons for use, perceptions, and effects on health.

Authors:  Sakshi Sapru; Mridula Vardhan; Qianhao Li; Yuqi Guo; Xin Li; Deepak Saxena
Journal:  BMC Public Health       Date:  2020-10-09       Impact factor: 3.295

8.  E-cigarettes compromise the gut barrier and trigger inflammation.

Authors:  Aditi Sharma; Jasper Lee; Ayden G Fonseca; Alex Moshensky; Taha Kothari; Ibrahim M Sayed; Stella-Rita Ibeawuchi; Rama F Pranadinata; Jason Ear; Debashis Sahoo; Laura E Crotty-Alexander; Pradipta Ghosh; Soumita Das
Journal:  iScience       Date:  2021-01-06

Review 9.  A roadmap from unknowns to knowns: Advancing our understanding of the microbiomes of commercially available tobacco products.

Authors:  Suhana Chattopadhyay; Leena Malayil; Emmanuel F Mongodin; Amy R Sapkota
Journal:  Appl Microbiol Biotechnol       Date:  2021-03-11       Impact factor: 5.560

10.  Periodontal dysbiosis associates with reduced CSF Aβ42 in cognitively normal elderly.

Authors:  Angela R Kamer; Smruti Pushalkar; Deepthi Gulivindala; Tracy Butler; Yi Li; Kumar Raghava Chowdary Annam; Lidia Glodzik; Karla V Ballman; Patricia M Corby; Kaj Blennow; Henrik Zetterberg; Deepak Saxena; Mony J de Leon
Journal:  Alzheimers Dement (Amst)       Date:  2021-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.